We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTHI
2626
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$99K ﹤0.01%
+30,700
New +$87.1K
APYX icon
2627
Apyx Medical
APYX
$164M
$98K ﹤0.01%
+33,300
New +$112K
BDL icon
2628
Flanigan's Enterprises
BDL
$70.5M
$98K ﹤0.01%
+10,400
New +$97K
TREC
2629
DELISTED
Trecora Resources
TREC
$98K ﹤0.01%
+11,300
New +$89.2K
UPI
2630
DELISTED
UROPLASTY INC-NEW
UPI
$98K ﹤0.01%
+47,300
New +$108K
IFT
2631
DELISTED
IMPERIAL HLDGS INC COM STK (FL)
IFT
$97K ﹤0.01%
+14,200
New +$81.9K
MATR
2632
DELISTED
Mattersight Corp.
MATR
$96K ﹤0.01%
+34,300
New +$132K
EFUT
2633
DELISTED
eFuture Holding Inc. Ordinary Shares
EFUT
$95K ﹤0.01%
+37,100
New +$111K
SURG
2634
DELISTED
SYNERGETICS USA, INC.
SURG
$95K ﹤0.01%
+24,200
New +$79.8K
ESSX
2635
DELISTED
ESSEX RENTAL CORP. COMMON STOCK
ESSX
$94K ﹤0.01%
+21,700
New +$93.9K
ELTK icon
2636
Eltek
ELTK
$61.5M
$92K ﹤0.01%
+16,360
New +$98.7K
TSRI
2637
DELISTED
TSR Inc. New
TSRI
$92K ﹤0.01%
+30,650
New +$98.3K
VRNM
2638
DELISTED
VERENIUM CORP COM STK (US)
VRNM
$92K ﹤0.01%
+41,200
New +$94.6K
SLNG icon
2639
Stabilis Solutions
SLNG
$89.3M
$91K ﹤0.01%
+1,588
New +$75.8K
ONCY
2640
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
$91K ﹤0.01%
+31,500
New +$87.1K
YTEN
2641
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$90K ﹤0.01%
+1
New +$96.7K
ADAT
2642
DELISTED
AUTHENTIDATE HOLDING CORP COM STK (DE)
ADAT
$89K ﹤0.01%
+11,378
New +$112K
VSCI
2643
DELISTED
VISION SCIENCES INC (DEL)
VSCI
$89K ﹤0.01%
+87,500
New +$89.9K
CIVB icon
2644
Civista Bancshares
CIVB
$595M
$88K ﹤0.01%
+12,200
New +$88.9K
SWSH
2645
DELISTED
SWISHER HYGIENE INC COM STK NEW (DE)
SWSH
$87K ﹤0.01%
+10,160
New +$116K
ZX
2646
DELISTED
China Zenix Auto Internatl Ltd
ZX
$87K ﹤0.01%
+33,400
New +$94.9K
STB
2647
DELISTED
Student Transportation Inc
STB
$85K ﹤0.01%
+13,912
New +$84K
ABCD
2648
DELISTED
Cambium Learning Group, Inc.
ABCD
$84K ﹤0.01%
+66,500
New +$77.4K
LIME
2649
DELISTED
LIME ENERGY CO.NEW COMMON STOCK
LIME
$84K ﹤0.01%
+18,214
New +$95K
BTUI
2650
DELISTED
BTU INTERNATIONAL INC
BTUI
$82K ﹤0.01%
+34,000
New +$78.3K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.